Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Nuo Therapeutics, Inc. | v417065_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - Nuo Therapeutics, Inc. | v417065_ex32-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Nuo Therapeutics, Inc. | v417065_ex31-1.htm |
| XML - IDEA: XBRL DOCUMENT - Nuo Therapeutics, Inc. | R9999.htm |
| 10-Q - FORM 10-Q - Nuo Therapeutics, Inc. | v417065_10q.htm |
Exhibit 32.1
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. §1350 and in connection with the Quarterly Report on Form 10-Q of Nuo Therapeutics, Inc. (the “Company”) for the period ended June 30, 2015 (the “Report”), I, Martin P. Rosendale, Chief Executive Officer of the Company, hereby certify, that, to my knowledge:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: August 13, 2015 | /s/ Martin P. Rosendale | |
| Martin P. Rosendale | ||
| Chief Executive Officer | ||
| (Principal Executive Officer) |